Intrapulmonary percussive ventilation (IPV) therapy is an airway clearance therapy that combines percussion, high-velocity flow, and entrainment to mobilize secretions and address gas exchange impairment. The therapy can be delivered through a mouthpiece or mask, directly to the airway, or in-line with a ventilator, making it versatile for a range of patient populations.

The IPVⓇ 1 is a safe and effective airway clearance device that builds on the Percussionaire legacy of IPV therapy with a Unified Connector that supports patient safety, a patient-friendly interface, and the unique efficacy of the Phasitron.

Along with IPV therapy’s clinical results in treating patients with respiratory complications, it has a demonstrated history of being safe and well-tolerated across diverse patient populations, care settings, and delivery interfaces.

There is a long list of decisions to make when adopting new technology in a hospital unit, and transcutaneous monitoring is no exception. Some of the most overlooked decisions in our experience are those around mounting and storing the devices both during monitoring, while not in use, as well as for performing maintenance.